CSL.AX
CSL Ltd
Price:  
121.95 
AUD
Volume:  
1,047,549.00
Australia | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CSL.AX EV/EBITDA

150.7%
Upside

As of 2026-07-17, the EV/EBITDA ratio of CSL Ltd (CSL.AX) is 14.41. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CSL.AX's latest enterprise value is 72,800.99 mil AUD. CSL.AX's TTM EBITDA according to its financial statements is 5,052.00 mil AUD. Dividing these 2 quantities gives us the above CSL.AX EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 23.9x - 38.8x 24.7x
Forward P/E multiples 16.7x - 19.3x 18.1x
Fair Price 242.57 - 559.96 305.74
Upside 98.9% - 359.2% 150.7%
121.95 AUD
Stock Price
305.74 AUD
Fair Price

CSL.AX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-07-16 13.60
2026-07-15 13.51
2026-07-14 13.58
2026-07-13 13.48
2026-07-10 13.57
2026-07-09 13.94
2026-07-08 13.72
2026-07-07 13.78
2026-07-06 13.76
2026-07-03 13.51
2026-07-02 13.16
2026-07-01 13.17
2026-06-30 12.84
2026-06-29 12.92
2026-06-26 12.91
2026-06-25 13.14
2026-06-24 12.90
2026-06-23 12.62
2026-06-22 12.59
2026-06-19 13.00
2026-06-18 12.19
2026-06-17 12.08
2026-06-16 12.05
2026-06-15 11.98
2026-06-12 12.18
2026-06-11 12.20
2026-06-10 11.73
2026-06-09 11.41
2026-06-05 11.23
2026-06-04 10.74
2026-06-03 10.72
2026-06-02 10.71
2026-06-01 10.92
2026-05-29 11.14
2026-05-28 11.26
2026-05-27 11.39
2026-05-26 11.18
2026-05-25 11.29
2026-05-22 11.42
2026-05-21 11.43
2026-05-20 11.31
2026-05-19 11.29
2026-05-18 11.08
2026-05-15 11.31
2026-05-14 11.15
2026-05-13 11.34
2026-05-12 11.40
2026-05-11 11.58
2026-05-08 13.41
2026-05-07 13.62